Vident Advisory »

Corcept Therapeutics Incorporated shares owned by Vident Advisory

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Vident Advisory from 13F filings

Historical chart of Vident Advisory investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Vident Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Vident Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.6M 182k 25.19
2023-12-31 $2.9M 88k 32.48
2023-09-30 $2.4M 88k 27.25

More positions owned by Vident Advisory

UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
NVIDIA Corporation (NVDA)
Abbvie (ABBV)
Cisco Systems (CSCO)
Apple (AAPL)
Broadcom (AVGO)
Etf Ser Solutions Vident Us Equity (VUSE)
Bristol Myers Squibb (BMY)
Cameco Corporation (CCJ)
Metropcs Communications (TMUS)
Amazon (AMZN)
Comcast Corp Cl A (CMCSA)

View all positions for Vident Advisory

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated